On the other hand, as an attractive target of MAIT cells, MR1 needs to be better explored for the mechanisms of hematological disease-associated antigens and antigen/MR1 complexes presented in MR1 to successfully target MAIT cells to tumors. Here, MR1 is linked to hematologic disorder.